Surgery Partners (NASDAQ:SGRY) Shares Down 3.3% – Should You Sell?

Posted by George Bondi on Sep 17th, 2026

Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report)’s share price was down 3.3% during mid-day trading on Thursday . The company traded as low as $13.26 and last traded at $13.4750. Approximately 911,074 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 1,666,342 shares. The stock had previously closed at $13.93.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Zacks Research lowered shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. JPMorgan Chase & Co. boosted their price target on Surgery Partners from $14.00 to $15.00 and gave the company a “neutral” rating in a report on Monday. Royal Bank Of Canada lowered their price target on Surgery Partners from $20.00 to $19.00 and set an “outperform” rating for the company in a research report on Tuesday, August 11th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $18.00 price objective on shares of Surgery Partners in a report on Tuesday, August 11th. Finally, TD Cowen lifted their price objective on Surgery Partners from $17.00 to $19.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Surgery Partners has a consensus rating of “Moderate Buy” and an average target price of $19.00.

View Our Latest Analysis on SGRY

Surgery Partners Price Performance

The company has a current ratio of 1.95, a quick ratio of 1.78 and a debt-to-equity ratio of 1.18. The business’s 50 day moving average price is $14.95 and its two-hundred day moving average price is $14.28. The stock has a market cap of $1.79 billion, a P/E ratio of -19.52, a price-to-earnings-growth ratio of 3.75 and a beta of 1.92.

Surgery Partners (NASDAQ:SGRY – Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company had revenue of $848.90 million during the quarter, compared to the consensus estimate of $830.03 million. During the same period in the prior year, the firm earned $0.17 earnings per share. Surgery Partners’s revenue was up 2.7% on a year-over-year basis. As a group, sell-side analysts expect that Surgery Partners, Inc. will post 0.25 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Teresa DeLuca bought 10,000 shares of the stock in a transaction dated Tuesday, August 18th. The stock was bought at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the purchase, the director directly owned 66,843 shares in the company, valued at $959,197.05. This trade represents a 17.59% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Surgery Partners

Institutional investors have recently added to or reduced their stakes in the company. Corient Private Wealth LP purchased a new stake in shares of Surgery Partners in the 2nd quarter worth approximately $1,211,000. Irenic Capital Management LP increased its position in Surgery Partners by 740.2% during the 1st quarter. Irenic Capital Management LP now owns 711,000 shares of the company’s stock valued at $8,475,000 after buying an additional 626,380 shares in the last quarter. Varde Management L.P. raised its stake in Surgery Partners by 32.8% during the second quarter. Varde Management L.P. now owns 1,003,447 shares of the company’s stock valued at $16,858,000 after buying an additional 248,009 shares during the last quarter. Quantinno Capital Management LP raised its stake in Surgery Partners by 435.0% during the first quarter. Quantinno Capital Management LP now owns 82,520 shares of the company’s stock valued at $984,000 after buying an additional 67,095 shares during the last quarter. Finally, Jupiter Topco LLC bought a new stake in Surgery Partners in the second quarter worth $233,220,000.

About Surgery Partners

(Get Free Report)

Surgery Partners, Inc (NASDAQ: SGRY) is a healthcare services company that owns and operates a network of ambulatory surgery centers and surgical hospitals in the United States. The company works with physicians and health systems to provide outpatient and same-day surgical care in settings outside traditional hospital facilities.

Its services cover a range of specialties, including orthopedics, pain management, gastroenterology, ophthalmology, gynecology, urology and other procedural areas.